(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Ciencias Cardiovasculares > Cardiopatía hipertensiva > DA - CIMA - Cardiovasculares - Cardiopatía hipertensiva - Artículos de Revista >

The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data
Autor(es) : Dzau, V.J. (Victor J.)
Bernstein, K. (Kenneth)
Celermajer, D. (David)
Cohen, J. (Jerome)
Dahlöf, B. (Björn)
Deanfield, J. (John)
Diez, J. (Javier)
Drexler, H. (Helmut)
Ferrari, R. (Roberto)
Van-Gilst, W. (Wiek)
Hansson, L. (Lennart)
Hornig, B. (Burkhard)
Husain, A. (Ahsan)
Johnston, C. (Colin)
Lazar, H. (Harold)
Lonn, E. (Eva)
Lüscher, T. (Thomas)
Mancini, J. (John)
Mimran, A. (Albert)
Pepine, C. (Carl)
Rabelink, T. (Ton)
Remme, W. (Willem)
Ruilope, L.M. (Luis M.)
Ruzicka, M. (Marcel)
Schunkert, H. (Heribert)
Swedberg, K. (Karl)
Unger, T. (Thomas)
Vaughan, D. (Douglas)
Weber, M. (Michael)
Palabras clave : Peptidyl-Dipeptidase A/physiology
Fecha incorporación: 2001
Editorial : Elsevier
Versión del editor: http://www.sciencedirect.com/science/article/pii/S0002914901018781
ISSN: 1879-1913
Cita: Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlof B, Deanfield J, et al. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol 2001 Nov 8;88(9A):1L-20L.
Resumen
Angiotensin-converting enzyme (ACE) is primarily localized (>90%) in various tissues and organs, most notably on the endothelium but also within parenchyma and inflammatory cells. Tissue ACE is now recognized as a key factor in cardiovascular and renal diseases. Endothelial dysfunction, in response to a number of risk factors or injury such as hypertension, diabetes mellitus, hypercholesteremia, and cigarette smoking, disrupts the balance of vasodilation and vasoconstriction, vascular smooth muscle cell growth, the inflammatory and oxidative state of the vessel wall, and is associated with activation of tissue ACE. Pathologic activation of local ACE can have deleterious effects on the heart, vasculature, and the kidneys. The imbalance resulting from increased local formation of angiotensin II and increased bradykinin degradation favors cardiovascular disease. Indeed, ACE inhibitors effectively reduce high blood pressure and exert cardio- and renoprotective actions. Recent evidence suggests that a principal target of ACE inhibitor action is at the tissue sites. Pharmacokinetic properties of various ACE inhibitors indicate that there are differences in their binding characteristics for tissue ACE. Clinical studies comparing the effects of antihypertensives (especially ACE inhibitors) on endothelial function suggest differences. More comparative experimental and clinical studies should address the significance of these drug differences and their impact on clinical events.
Enlace permanente: http://hdl.handle.net/10171/21895
Aparece en las colecciones: DA - CIMA - Cardiovasculares - Cardiopatía hipertensiva - Artículos de Revista

Ficheros en este registro:
Fichero:  AmJCardiol2001_881L.pdf
Descripción: 
Tamaño:  527,62 kB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.